We are excited to showcase @FocalOneHIFU at the 2026 British Association of Urological Surgeons (@BAUSurology) Annual Meeting, a flagship event in the field of urology, highlighting the latest developments in clinical practice, surgical innovation, and research in the UK.
Join us in London from June 15-17 to discover the latest generation Focal One® i system, explore its role in focal therapy, and connect with our team.
Schedule a Hands-On Simulation at our booth: https://t.co/CeUX9kO7r7.
#BAUS2026 | #RoboticSurgery | #MedTech | #HIFU | #Cancer | #ProstateCancer | #Urology
Today marks an exciting new chapter for our company.
EDAP is now FocalTherics™ (NASDAQ: FOCL), a name that reflects our exclusive focus on advancing robotic focal therapy and our commitment to transforming the treatment of prostate cancer, benign prostatic hyperplasia (BPH), and endometriosis through innovative, minimally invasive technology.
While our name has changed, our mission remains the same: driving innovation, supporting physicians, and improving patient outcomes through precision-focused therapy.
To learn more about the latest updates on the company's growth strategy, expanding therapeutic indications, and leadership through innovation and advanced technologies, visit the link below:
https://t.co/4jcbc3rLvf
#Cancer | #ProstateCancer | #BPH | #Endometriosis | #Urology | #RoboticSurgery | #MedTech | #HIFU
@Nasdaq@FocalOneHIFU
An incredible week at #AUA26 in Washington, DC!
Thank you to the physicians, partners, and collaborators who visited the @FocalOneHIFU booth to discuss the evolving role of focal therapy and experience the latest advancements in Robotic Focal HIFU.
From daily educational sessions to hands-on demonstrations with the advanced Focal One i platform, this year’s meeting highlighted the growing momentum and leadership driving innovation in the management of prostate cancer.
We appreciate the opportunity to connect with leaders across the urological community and look forward to continuing these important conversations beyond AUA2026.
To learn more about @FocalOneHIFU, visit https://t.co/8cSMhhrefq.
#Cancer | #ProstateCancer | #Urology | #HIFU | #RoboticSurgery | #MedTech | @AmerUrological
Only 2 days until AUA2026 kicks off in Washington, DC!
Join us at @FocalOneHIFU Booth #1427 to discover how Robotic Focal HIFU is transforming the management of prostate cancer and shaping the future of focal therapy.
Meet our experts, connect with leading physicians, and explore the latest innovations driving precision urology and non-invasive treatment approaches.
We look forward to seeing you at #AUA26!
View the full daily schedule here: https://t.co/ogh3jjsdM8.
#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU | @AmerUrological
Meet Urology Experts and Watch a LIVE @FocalOneHIFU Demonstration next week at the #AUA26 Annual Meeting in Washington, DC on May 15-17!
Focal therapy experts Jay Raman, MD (@urojdr), Eric Giesler, MD, and @TimDaskivich, MD will lead these demonstrations, showcasing the latest-generation Focal One i Robotic HIFU technology and its advanced innovations in imaging integration, precision targeting, and workflow efficiency.
Don’t miss a session — view the full schedule: https://t.co/ogh3jjsdM8.
#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU | @AmerUrological
🎯 Join us at @MSKCancerCenter for
Advanced Techniques in Target Prostate Biopsy & Focal Therapy in Prostate Cancer
Case-based interactive expert panels
📅 05/14/26 @ NYC 🗽🇺🇸
Perfect timing before heading to DC for #AUA2026 ✈️ 🚅
Free registration 🔗: https://t.co/7RVeEKZjd9
Join us at the #AUA26 Annual Meeting for a presentation by Pr. Pascal Rischmann, Principal Investigator of the HIFI Study, to explore the latest clinical evidence advancing focal therapy.
The HIFI Study, the largest prospective clinical study comparing localized prostate cancer treatments, enrolled 3,328 patients across 46 centers, including 1,967 HIFU patients and 1,361 Radical Prostatectomy (RP) patients—demonstrating key insights into treatment outcomes.
In addition, the HIFI-2 Study, recently published in European Urology Oncology, evaluated 531 patients across 32 sites and highlights the role of @FocalOneHIFU in managing radiorecurrent prostate cancer, showing strong oncologic control while preserving quality of life.
View the daily schedule at: https://t.co/ogh3jjsdM8.
#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU | @AmerUrological
Two weeks until #AUA2026!
Join us on Friday, May 15 for an in-depth session with Pr. Sébastien Crouzet: "Lessons Learned from 3000 Focal One Procedures + LIVE Focal One Demonstration.”
Experience @FocalOneHIFU in action and learn directly from a world-renowned, focal therapy expert. From patient selection to clinical application, gain insights shaped by 3,000 real-world cases.
View the full schedule: https://t.co/ogh3jjsdM8.
#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU | @AmerUrological
The HIFI-2 study, now published in European Urology Oncology, marks a major milestone in focal therapy. As the largest prospective clinical study of salvage HIFU following radiotherapy, it includes 531 patients across 30+ centers, offering real-world evidence.
Dr. Guillaume Ploussard, first author of the publication states, "This large prospective multicenter study demonstrates that salvage HIFU can achieve clinically meaningful oncologic control while maintaining an acceptable safety profile in patients with localized recurrence after radiotherapy."
This study reinforces the growing role of non-invasive, organ-preserving approaches such as @FocalOneHIFU in shaping the standard of care for prostate cancer management.
Read the full press release: https://t.co/SA6hyADlqr.
#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU
Visit the Focal One booth at the #AUA26 Annual Meeting on May 15-17 in Washington DC! We'll be featuring Semi-Live @FocalOneHIFU Procedures presented by focal therapy experts Amir Lebastchi, MD, James Wysock, MD, and @TarikBenidir, MD, with unique insights on their experience with the technology.
View the full schedule at: https://t.co/ogh3jjsdM8.
#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU | @AmerUrological
As the management of localized #ProstateCancer shifts from whole-gland treatment toward more tailored interventions, the ability to accurately detect and localize disease is paramount. Join us for a comprehensive one-day course at @MSKCancerCenter, designed for #urologists seeking to master advanced MRI-targeted prostate biopsy techniques and novel focal therapy approaches.
Complimentary for all participants.
Special room rates offered.
Register: https://t.co/6qYL1aM9ix
@BehfarEhdaieMD@SeanFletcherMD
On March 28, we partnered with @nyulangone to hold the inaugural International Symposium on Robotic Focal Therapy in New York City, bringing together leading physicians from the U.S. and abroad.
The program fostered a high-level exchange of perspectives on focal therapy, real-world clinical experience, and the latest advancements shaping the field. Attendees also engaged in interactive, hands-on demonstrations with Focal One® i – the most advanced Robotic Focal HIFU technology.
Thank you to all who joined, and we hope the insights and discussions provided meaningful context for integrating focal therapy into a comprehensive cancer program.
#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #HIFU
Only 2 more days until the International Symposium on Robotic Focal Therapy at @nyulangone in New York City!
If you’re considering attending, take a moment to review the detailed program, which outlines key discussions on patient selection, treatment planning, real-world application of @FocalOneHIFU, and emerging research in focal therapy.
Register now! Space is limited: https://t.co/mnu1E8rk7q.
#Cancer | #ProstateCancer | #Urology | #MedTech | #RoboticSurgery | #HIFU
Learn from leading voices in urology at the inaugural International Symposium on Robotic Focal Therapy on March 28 in New York City at @nyulangone.
This interactive program will explore topics including:
• Patient selection
• Treatment planning
• Real-world outcomes and workflow with @FocalOneHIFU
• Emerging clinical research
• Integrating focal therapy into everyday practice
Connect with expert faculty and fellow urologists who are advancing innovation in the management of prostate cancer.
Seats are limited. Register here: https://t.co/mnu1E8rk7q.
#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU
Join us on March 28 in New York City at @nyulangone Health for the inaugural International Symposium on Robotic Focal Therapy.
Led by Course Directors James Wysock, MD and Herbert Lepor, MD, this focused program will feature in-depth talks designed for urologists. Sessions will cover patient selection, treatment planning, real-world outcomes and workflow with @FocalOneHIFU, emerging clinical research, and practical considerations for integrating focal therapy into clinical practice.
This is a unique opportunity to engage directly with peers and leaders advancing the field and gain insights for building a successful focal therapy program.
Register now! Space is limited: https://t.co/mnu1E8rk7q.
#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU
EAU 2026 – Just one week away!
From March 13-16, the global urology community will gather for the annual @Uroweb European Association of Urology (EAU) Congress.
Visit us at Booth E22 and discover Focal One® i, our next-generation Robotic HIFU system, and connect with our team to discuss the ongoing evolution of focal therapy.
Join us to:
✔️ Learn more about the latest advancements in our technology
✔️ Explore new collaboration opportunities
✔️ Experience hands-on simulations
We look forward to seeing you in London!
#EAU2026 | #Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU
Introducing the new Focal One® i Embedded Video Library, delivering in-system video content for real-time learning. Users can access procedural refreshers and best practices on demand.
To discover @FocalOneHIFU i, visit https://t.co/zgqrKrafAJ.
#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU
Join us for the inaugural International Symposium on Robotic Focal Therapy on March 28 in New York City at @nyulangone.
This focused educational program will feature expert-led lectures on focal therapy and prostate cancer management, real-world insights on @FocalOneHIFU outcomes and workflow, discussion on clinical research and collaboration, and practical guidance for building a successful focal therapy program.
Register now! Limited space available: https://t.co/mnu1E8rk7q.
#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU
EAU 2026: Save the Date
Join us at the annual @Uroweb European Association of Urology (EAU) Congress in London from March 13-16!
Discover the latest generation Focal One i technology and engage in meaningful discussions on advancements in prostate cancer management.
Visit us at Booth E22 to meet our experts, experience hands-on demonstrations, and learn more about @FocalOneHIFU and its role in Focal Therapy.
#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech | #HIFU
@FocalOneHIFU allows urologists to target only the diseased portion of the prostate, minimizing the risk of damage to surrounding healthy tissue leading to less side effects.
There is no blood loss, no scar, and no radiation involved in this procedure.
To learn more, visit https://t.co/8cSMhhrefq.
#Cancer | #ProstateCancer | #Urology | #RoboticSurgery | #MedTech